Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2020 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2020 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression

  • Authors:
    • Yuan Hu
    • Xianzhe Dong
    • Tianyi Zhang
    • Hongming Ma
    • Wenshan Yang
    • Yichen Wang
    • Ping Liu
    • Yibang Chen
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Pharmacology, Pharmacy Care Center, Chinese PLA General Hospital, Beijing 100853, P.R. China, Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing 100053, P.R. China, Department of Pharmacology and System Therapeutics, Mount Sinai School of Medicine, New York, NY 10029, USA
  • Pages: 508-516
    |
    Published online on: November 6, 2019
       https://doi.org/10.3892/mmr.2019.10807
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Depression is often triggered by prolonged exposure to psychosocial stressors and associated with coronary heart disease (CHD). Matrix metalloproteinases (MMPs) are involved in the pathogenesis of various emotional and cardiovascular disorders. The purpose of this study was to investigate whether Kai‑Xin‑San (KXS), which may terminate the signaling of MMPs, exerts antidepressant‑like and cardioprotective effects in a myocardial infarction (MI) plus depression rat model. Rats were randomly assigned to five groups: A normal control (control group), a celisc‑injection of isopropyl adrenaline group (ISO group), depression (depression group), an ISO + depression (depression + ISO group), and an ISO + depression group treated with intragastric administration of 1,785 mg/kg KXS (KXS group). Behavioral changes, echocardiography, biochemical index, matrix metalloproteinase (MMP) and apoptosis‑related proteins were assessed. Compared with the depression + ISO group, KXS significantly improved stress‑induced alterations of behavioral parameters and protected the heart by enlarging the left ventricular (LV) fractional shortening (FS) and LV ejection fraction (EF). Moreover, KXS significantly attenuated ISO + depression‑induced MMP‑2 and MMP‑9 expression at the mRNA and protein level and decreased TIMP in the heart compared to the complex model group. Myocardial apoptosis was significantly attenuated by KXS by regulating the Bcl‑2/Bax axis. These results indicated that MI comorbid with depression may damage the MMP balance in the central and peripheral system, and KXS may have a direct anti‑depressive and cardio‑protective effect by regulating the level of MMPs and associated myocardial apoptosis. It is promising to further explore the clinical potential of KXS for the therapy or prevention of MI plus depression comorbidity disease.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Halaris A: Psychocardiology: Moving toward a new subspecialty. Future Cardiol. 9:635–640. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM and Topol EJ: Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 290:898–904. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Soufer R, Jain H and Yoon AJ: Heart-brain interactions in mental stress-induced myocardial ischemia. Curr Cardiol Rep. 11:133–140. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Sanner JE, Frazier L and Udtha M: The role of platelet serotonin and depression in the acute coronary syndrome population. Yale J Biol Med. 86:5–13. 2013.PubMed/NCBI

5 

Ladwig KH, Baumert J, Marten-Mittag B, Lukaschek K, Johar H, Fang X, Ronel J, Meisinger C, Peters A and KORA Investigators: Room for depressed and exhausted mood as a risk predictor for all-cause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men. Atherosclerosis. 257:224–231. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, et al: Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the american heart association. Circulation. 129:1350–1369. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Roose SP and Spatz E: Treating depression in patients with ischaemic heart disease: Which agents are best to use and to avoid? Drug Saf. 20:459–465. 1999. View Article : Google Scholar : PubMed/NCBI

8 

He DF, Ren YP and Liu MY: Effects of ginseng fruit saponins on serotonin system in sprague-dawley rats with myocardial infarction, depression, and myocardial infarction complicated with Depression. Chin Med J (Engl). 129:2913–2919. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Wang Y, Zhang H, Chai F, Liu X and Berk M: The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression. BMC Psychiatry. 14:3492014. View Article : Google Scholar : PubMed/NCBI

10 

Liang J, Yuan X, Shi S, Wang F, Chen Y, Qu C, Chen J, Hu D and Yang B: Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression. Drug Des Devel Ther. 9:763–772. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Wang C, Hou J, Du H, Yan S, Yang J, Wang Y, Zhang X, Zhu L and Zhao H: Anti-depressive effect of Shuangxinfang on rats with acute myocardial infarction: Promoting bone marrow mesenchymal stem cells mobilization and alleviating inflammatory response. Biomed Pharmacother. 111:19–30. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Mayer F, Falk M, Huhn R, Behmenburg F and Ritz-Timme S: Matrixmetalloproteinases and tissue inhibitors of metalloproteinases: Immunhistochemical markers in the diagnosis of lethal myocardial infarctions? Forensic Sci Int. 288:181–188. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Hojo Y, Ikeda U, Ueno S, Arakawa H and Shimada K: Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Cir J. 65:71–75. 2001. View Article : Google Scholar

14 

Cadete VJ, Arcand SA, Chaharyn BM, Doroszko A, Sawicka J, Mousseau DD and Sawicki G: Matrix metalloproteinase-2 is activated during ischemia/reperfusion in a model of myocardial infarction. Can J Cardiol. 29:1495–1503. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Bobinska K, Szemraj J, Galecki P and Talarowska M: The role of MMP genes in recurrent depressive disorders and cognitive functions. Acta Neuropsychiatr. 28:221–231. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Wang AL, Chen Z, Luo J, Shang QH and Xu H: Systematic review on randomized controlled trials of coronary heart disease complicated with depression treated with chinese herbal medicines. Chin J Integr Med. 22:56–66. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Hu Y, Liu M, Liu P, Yan JJ, Liu MY, Zhang GQ, Zhou XJ and Yu BY: Effect of Kai Xin San on learning and memory in a rat model of paradoxical sleep deprivation. J Med Food. 16:280–287. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Wang N, Jia YM, Zhang B, Xue D, Reeju M, Li Y, Huang SM and Liu XW: Neuroprotective mechanism of Kai Xin San: Upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation. Neural Regen Res. 12:654–659. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Dong XZ, Wang DX, Lu YP, Yuan S, Liu P and Hu Y: Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats. Braz J Med Biol Res. 50:e61612017. View Article : Google Scholar : PubMed/NCBI

20 

Hu Y, Zhou XJ, Liu P, Dong XZ, Mu LH, Chen YB, Liu MY and Yu BY: Antidepressant and neuroprotective effect of the chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-induced injury in vitro and in vivo. Neuropsychobiology. 69:129–139. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Zhu Y, Chao C, Duan X, Cheng X, Liu P, Su S, Duan J, Dong TT and Tsim KW: Kai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus. Sci Rep. 7:14672017. View Article : Google Scholar : PubMed/NCBI

22 

Liu XY, Zhou XY, Hou JC, Zhu H, Wang Z, Liu JX and Zheng YQ: Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway. Acta Pharmacol Sin. 36:421–428. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Jung JY, Seong KJ, Moon IO, Cho JH, Kim SH and Kim WJ: Ginsenosides have a suppressive effect on c-Fos expression in brain and reduce cardiovascular responses increased by noxious stimulation to the rat tooth. Korean J Physiol Pharmacol. 17:121–125. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Wang QW, Yu XF, Xu HL, Jiang YC, Zhao XZ and Sui DY: Ginsenoside re attenuates isoproterenol-induced myocardial injury in rats. Evid Based Complement Alternat Med. 2018:86371342018.PubMed/NCBI

25 

Zhao Z, Fang M, Xiao D, Liu M, Fefelova N, Huang C, Zang WJ and Xie LH: Potential antiarrhythmic effect of methyl 3,4,5-trimethoxycinnamate, a bioactive substance from roots of polygalae radix: Suppression of triggered activities in rabbit myocytes. Biol Pharm Bull. 36:238–244. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Hu Y, Liu M, Liu P, Guo DH, Wei RB and Rahman K: Possible mechanism of the antidepressant effect of 3,6′-disinapoyl sucrose from polygala tenuifolia willd. J Pharm Pharmacol. 63:869–874. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Zhang X, Gao Y, Dong J, Wang S, Yao B, Zhang J, Hu S, Xu X, Zuo H, Wang L, et al: The compound chinese medicine ‘Kang Fu Ling’ protects against high power microwave-induced myocardial injury. PLoS One. 9:e1015322014. View Article : Google Scholar : PubMed/NCBI

28 

Hu Y, Cao Y, Liu M, Liu P, Cui H and Dai-Hong G: Behavioral and biochemical effects of a formulation of the traditional chinese medicine, Kai-Xin-San, in fatigued rats. Exp Ther Med. 6:973–976. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Hu Y, Liu P, Dai-Hong G, Rahman K, Wang DX, Chen ML and Xie TT: Behavioral and biochemical effects of kaixin-san, a traditional Chinese medicinal empirical formula. Drug Dev Res. 69:267–271. 2008. View Article : Google Scholar

30 

Lin Y, Wang LN, Xi YH, Li HZ, Xiao FG, Zhao YJ, Tian Y, Yang BF and Xu CQ: L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Basic Clin Pharmacol Toxicol. 103:124–130. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, Xue YX, Ding ZB, Shi J and Lu L: PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology. 37:2671–2683. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Porsolt RD, Le Pichon M and Jalfre M: Depression: A new animal model sensitive to antidepressant treatments. Nature. 266:730–732. 1977. View Article : Google Scholar : PubMed/NCBI

33 

Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC, Thibault H, Scherrer-Crosbie M, Schmidt U and Chao W: Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol. 295:H1311–H1318. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

35 

Arseneault-Breard J, Rondeau I, Gilbert K, Girard SA, Tompkins TA, Godbout R and Rousseau G: Combination of lactobacillus helveticus R0052 and bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr. 107:1793–1799. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P and Lee RT: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 99:3063–3070. 1999. View Article : Google Scholar : PubMed/NCBI

37 

Iyer RP, de Castro Bras LE, Patterson NL, Bhowmick M, Flynn ER, Asher M, Cannon PL, Deleon-Pennell KY, Fields GB and Lindsey ML: Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution. J Mol Cell Cardiol. 100:109–117. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Frangogiannis NG: Pathophysiology of myocardial infarction. Compr Physiol. 5:1841–1875. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Raish M: Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-κB signaling pathway. Int J Biol Macromol. 97:544–551. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Crow MT: The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res. 95:957–970. 2004. View Article : Google Scholar : PubMed/NCBI

41 

Zhang W, Li Y and Ge Z: Cardiaprotective effect of crocetin by attenuating apoptosis in isoproterenol induced myocardial infarction rat model. Biomed Pharmacother. 93:376–382. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, de Rienzo A, Roncarati R, Trimarco B and Lembo G: Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 99:3071–3078. 1999. View Article : Google Scholar : PubMed/NCBI

43 

Song YH, Cai H, Gu N, Qian CF, Cao SP and Zhao ZM: Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. J Pharm Pharmacol. 63:541–549. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Chen SL, Hu ZY, Zuo GF, Li MH and Li B: I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice. BMC Cardiovasc Disord. 14:1502014. View Article : Google Scholar : PubMed/NCBI

45 

Diao SL, Xu HP, Zhang B, Ma BX and Liu XL: Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation. Med Sci Monit. 22:1497–1507. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Xu YM, Wang XC, Xu TT, Li HY, Hei SY, Luo NC, Wang H, Zhao W, Fang SH, Chen YB, et al: Kai xin san ameliorates scopolamine-induced cognitive dysfunction. Neural Regen Res. 14:794–804. 2019. View Article : Google Scholar : PubMed/NCBI

47 

Chen C, Hu Y, Dong XZ, Zhou XJ, Mu LH and Liu P: Proteomic analysis of the antidepressant effects of shen-zhi-ling in depressed patients: Identification of proteins associated with platelet activation and lipid metabolism. Cell Mol Neurobiol. 38:1123–1135. 2018. View Article : Google Scholar : PubMed/NCBI

48 

Robert S, Gicquel T, Bodin A, Lagente V and Boichot E: Characterization of the MMP/TIMP imbalance and collagen production induced by IL-1β or TNF-α release from human hepatic stellate cells. PLoS One. 11:e01531182016. View Article : Google Scholar : PubMed/NCBI

49 

Gresele P, Falcinelli E, Sebastiano M and Momi S: Matrix metalloproteinases and platelet function. Prog Mol Biol Transl Sci. 147:133–165. 2017. View Article : Google Scholar : PubMed/NCBI

50 

Bobinska K, Szemraj J, Czarny P and Galecki P: Expression and activity of metalloproteinases in depression. Med Sci Monit. 22:1334–1341. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Chen Q, Jin M, Yang F, Zhu J, Xiao Q and Zhang L: Matrix metalloproteinases: Inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013:9283152013. View Article : Google Scholar : PubMed/NCBI

52 

Xu S, Webb SE, Lau TCK and Cheng SH: Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration. Sci Rep. 8:71992018. View Article : Google Scholar : PubMed/NCBI

53 

De Luca C and Papa M: Matrix metalloproteinases, neural extracellular matrix, and central nervous system pathology. Prog Mol Biol Transl Sci. 148:167–202. 2017. View Article : Google Scholar : PubMed/NCBI

54 

Tai SH, Chen HY, Lee EJ, Chen TY, Lin HW, Hung YC, Huang SY, Chen YH, Lee WT and Wu TS: Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res. 49:332–341. 2010. View Article : Google Scholar : PubMed/NCBI

55 

Nakaji K, Ihara M, Takahashi C, Itohara S, Noda M, Takahashi R and Tomimoto H: Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 37:2816–2823. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu Y, Dong X, Zhang T, Ma H, Yang W, Wang Y, Liu P and Chen Y: Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression. Mol Med Rep 21: 508-516, 2020.
APA
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y. ... Chen, Y. (2020). Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression. Molecular Medicine Reports, 21, 508-516. https://doi.org/10.3892/mmr.2019.10807
MLA
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y., Liu, P., Chen, Y."Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression". Molecular Medicine Reports 21.1 (2020): 508-516.
Chicago
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y., Liu, P., Chen, Y."Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression". Molecular Medicine Reports 21, no. 1 (2020): 508-516. https://doi.org/10.3892/mmr.2019.10807
Copy and paste a formatted citation
x
Spandidos Publications style
Hu Y, Dong X, Zhang T, Ma H, Yang W, Wang Y, Liu P and Chen Y: Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression. Mol Med Rep 21: 508-516, 2020.
APA
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y. ... Chen, Y. (2020). Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression. Molecular Medicine Reports, 21, 508-516. https://doi.org/10.3892/mmr.2019.10807
MLA
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y., Liu, P., Chen, Y."Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression". Molecular Medicine Reports 21.1 (2020): 508-516.
Chicago
Hu, Y., Dong, X., Zhang, T., Ma, H., Yang, W., Wang, Y., Liu, P., Chen, Y."Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression". Molecular Medicine Reports 21, no. 1 (2020): 508-516. https://doi.org/10.3892/mmr.2019.10807
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team